Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study. (OPT-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03500068
Recruitment Status : Recruiting
First Posted : April 17, 2018
Last Update Posted : April 23, 2018
Erasmus Medical Center
Information provided by (Responsible Party):
J.W. Wilmink, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 1, 2019
Estimated Study Completion Date : September 1, 2019